Skip to main content

Naqi Logix

Category: Robotics / Embodied AI

A non-invasive neural interface platform that enables users to control digital devices, wheelchairs, and smart environments through invisible micro-gestures and biosignals. Naqi Logix was founded in 2020. The company is led by Mark Godsy. Based in Vancouver, Canada. Team size: 11-50. Total funding raised: $9.6M. Latest round: Reg A+ Crowdfunding. Key investors include White Rose Ventures, Startup Warrior, National Research Council of Canada (NRC IRAP), StartEngine Crowdfunding.

Founded
2020
Headquarters
Vancouver, Canada
Team size
11-50
Total funding
$9.6M

Value proposition

Provides a high-bandwidth 'brain-to-device' connection without the need for invasive brain surgery, offering a silent, invisible, and hands-free alternative to voice or eye-tracking interfaces.

Products and solutions

Naqi Neural Earbuds (Flagship wearable hardware), Naqi Neural Framework (Software SDK for third-party device integration), Neural Wheelchair Control System (Specialized mobility solution), Wisear Biosensing Integration (Enhanced neural signal processing via acquired tech)

Unique value

Utilizes proprietary sensors to detect 'invisible' micro-gestures (ear and facial muscle movements) that are translated into complex digital commands, bypassing the need for physical movement or voice.

Target customer

Individuals with physical disabilities (quadriplegia, ALS), professional gamers, industrial workers requiring hands-free operation, and smart home power users.

Industries served

Assistive Technology & Accessibility, Gaming & Augmented Reality, Industrial & Enterprise (Hands-free workflows), Smart Home & IoT

Technology advantage

Offers a non-invasive 'Neural Interface Moat' that works with standard earbud form factors, making it more socially acceptable and safer than brain implants (like Neuralink) while providing higher reliability than eye-tracking in outdoor or high-glare environments.

How they differentiate

Proprietary non-invasive 'Invisible User Interface' that detects micro-gestures (ear and facial muscle movements) via standard earbud form factors, bypassing the need for brain surgery or bulky EEG headsets.

Main competitors

Neuralink, Emotiv, Neurable, Synchron

Key partnerships

Wisear (Strategic acquisition for neural talent and IP), National Research Council of Canada (NRC IRAP) for R&D funding, StartEngine (Capital raising and community investor platform), Various accessibility advocacy groups and mobility device manufacturers

Notable customers

Permobil (Wheelchair integration), Black & Veatch (Industrial hands-free pilot)

Major milestones

CES 2026 Best of Innovation Award (Accessibility & Longevity), Acquisition of Wisear (2025) to strengthen neural interface talent and IP, CES 2025 TWICE Picks Award Winner, Gold Edison Award for Social & Cultural Impact (2024), TIME Best Inventions of 2023 (Special Mention)

Growth metrics

Secured 27 awarded patents; produced 60 pilot units; target valuation of $125M during 2024/2025 crowdfunding.

Market positioning

Pioneer in non-invasive neural interface accessibility and hands-free human-machine interaction (HMI).

Geographic focus

North America, Europe, and Asia-Pacific.

Patents and IP

Holds over 27 patents in signal acquisition, machine learning translation, and neural interface architecture (primarily authored by founder Dave Segal).

About Mark Godsy

Mark Godsy is a veteran serial entrepreneur and non-practicing lawyer with over 30 years of experience in scaling high-growth ventures. He is best known for co-founding two multi-billion dollar biotech firms: ID Biomedical (acquired by GSK for $1.7 billion) and Angiotech Pharmaceuticals (which reached a peak market cap of over $2 billion). He has also served as Executive Chairman of Exro Technologies and is the founder of Shackelford Pharma.

Official website: